Jupiter Neurosciences, Inc., a US-based clinical-stage pharmaceutical company, announced on Thursday that it has named Saleem Elmasri, CPA, as its new chief financial officer, effective 1 January 2023.

Elmasri has served as principal, at Titan Advisory Services LLC, managing director at DLA LLC, senior director for Pine Hill Group LLC, senior manager for PricewaterhouseCoopers LLP. He has more than 15 years of experience in financial and management consulting. He started his career at PricewaterhouseCoopers and worked with various Fortune 500 clients, primarily focused on the Life Sciences and Pharmaceutical industry. He has headed advisory practices at boutique consulting companies.

Christer Rosen, chairman & CEO, said, 'We are excited to announce Saleem joining our team and bringing his experience as a public company CFO to our Company. As we continue to strategically advance the development of our pipeline and pursue our public offering, Saleem's talents are an integral addition to our management team.'